tiprankstipranks
Trending News
More News >
Twist Bioscience Corp (TWST)
NASDAQ:TWST
US Market

Twist Bioscience (TWST) Financial Statements

Compare
1,197 Followers

Twist Bioscience Financial Overview

Twist Bioscience's market cap is currently $2.63B. The company's EPS TTM is $-0.45; its P/E ratio is -32.80; Twist Bioscience is scheduled to report earnings on November 14, 2025, and the estimated EPS forecast is $-0.42. See an overview of income statement, balance sheet, and cash flow financials.
Dec 25Dec 24Dec 23Dec 22Dec 21
Income Statement
Total Revenue$ 376.57M$ 312.97M$ 245.11M$ 203.56M$ 132.33M
Gross Profit$ 191.00M$ 133.35M$ 89.73M$ 84.23M$ 51.71M
Operating Income$ -136.26M$ -220.83M$ -217.16M$ -234.78M$ -152.73M
EBITDA$ -52.10M$ -176.71M$ -174.15M$ -211.68M$ -143.91M
Net Income$ -77.67M$ -208.73M$ -204.62M$ -217.86M$ -152.10M
Balance Sheet
Cash & Short-Term Investments$ 232.43M$ 276.40M$ 336.41M$ 504.97M$ 477.86M
Total Assets$ 641.86M$ 614.32M$ 776.40M$ 961.38M$ 702.10M
Total Debt$ 75.57M$ 85.03M$ 94.07M$ 94.91M$ 62.92M
Net Debt$ -107.48M$ -141.29M$ -192.40M$ -283.77M$ -402.91M
Total Liabilities$ 168.90M$ 141.63M$ 152.97M$ 171.99M$ 121.28M
Stockholders' Equity$ 472.96M$ 472.69M$ 623.43M$ 789.38M$ 580.82M
Cash Flow
Free Cash Flow$ -75.63M$ -69.17M$ -170.25M$ -226.24M$ -139.31M
Operating Cash Flow$ -47.63M$ -64.09M$ -142.47M$ -124.39M$ -112.24M
Investing Cash Flow$ -24.76M$ -3.07M$ 50.61M$ -232.93M$ 156.16M
Financing Cash Flow$ 28.54M$ 6.89M$ 911.00K$ 270.53M$ 329.18M
Currency in USD

Twist Bioscience Earnings and Revenue History

Twist Bioscience Debt to Assets

Twist Bioscience Cash Flow

Twist Bioscience Forecast EPS vs Actual EPS